 |
|
The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib
Dong Il Park, Sun Young Kim, Ju Ock Kim, Sung Soo Jung, Hee Sun Park, Jae Young Moon, Chae Uk Chung, Song Soo Kim, Jae Hee Seo, Jeong Eun Lee
Tuberc Respir Dis. 2015;78(4):315-320. Published online 2015 Oct 1 DOI: https://doi.org/10.4046/trd.2015.78.4.315
|
|
Citations to this article as recorded by
 Evaluation of the prognosis in patients with small-cell lung cancer treated by chemotherapy using tumor shrinkage rate-based radiomics
Yuchen Zhou, Zhonghan Wu, Haowen Wang, Ke Zhang, Hua Chen, Siyu Zhu, Andriamifahimanjaka Sitrakiniaina, Yanting Wu, Shaopeng Yang, Xiaobo Sun, Wenfeng Li, Xiaoming Lin, Jingjing Jin
European Journal of Medical Research.2024;[Epub] CrossRef Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
Joseph D. Butner, Prashant Dogra, Caroline Chung, Eugene J. Koay, James W. Welsh, David S. Hong, Vittorio Cristini, Zhihui Wang
npj Systems Biology and Applications.2024;[Epub] CrossRef Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change
Qingsong Li, Na Liang, Xia Zhang, Yi Zhang, Weiwei Ouyang, Shengfa Su, Zhu Ma, Yinxiang Hu, Yichao Geng, Xiaxia Chen, Bing Lu
Frontiers in Oncology.2021;[Epub] CrossRef Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth
Kaitlyn Johnson, Axel Gomez, Jackson Burton, Douglas White, Arijit Chakravarty, Annette Schmid, Dean Bottino
European Journal of Cancer.2019; 109: 196. CrossRef Tumor shrinkage rate as a potential marker for the prediction of long-term outcome in advanced non-small cell lung cancer treated with first-line tyrosine kinase inhibitors
Shanshan Yu, Xingchen Wang, Xiaoyan Wang, Xueyuan Wu, Rongrong Xu, Xiaoqi Wang, Xue Zhang, Chunhong Zhang, Kun Chen, Dezhi Cheng, Li Wenfeng
Journal of Cancer Research and Therapeutics.2019; 15(7): 1574. CrossRef
|